Evidence map›Paper›PMID 29147611›Full record

ArticleOncoimmunology

Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells

L Masuelli, M Granato, M Benvenuto, R Mattera, R Bernardini, M Mattei, G d'Amati, G D'Orazi, A Faggioni, R Bei and 1 more

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Progress in Redirecting Antiparasitic Drugs for Cancer Treatment.Drug design, development and therapy · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

L MasuelliDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
M GranatoDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
M BenvenutoDepartment of Clinical Sciences and Traslational Medicine, "Tor Vergata" University of Rome, Rome, Italy.
R MatteraDepartment of Clinical Sciences and Traslational Medicine, "Tor Vergata" University of Rome, Rome, Italy.
R BernardiniSTA, "Tor Vergata" University of Rome, Rome, Italy.
M MatteiSTA, "Tor Vergata" University of Rome, Rome, Italy.
G d'AmatiDepartment of Radiological, Oncological and Pathological Sciences, "Sapienza" University of Rome, Rome, Italy.
G D'OraziDepartment of Research, Advanced Diagnostics, and Technological Innovation, Regina Elena National Cancer Institute, Rome, Italy.
A FaggioniDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
R BeiDepartment of Clinical Sciences and Traslational Medicine, "Tor Vergata" University of Rome, Rome, Italy.
M CironeDepartment of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
Sapienza University of Rome · ITUniversity of Rome Tor Vergata · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is usually a pro-survival mechanism in cancer cells, especially in the course of chemotherapy, thus autophagy inhibition may enhance the chemotherapy-mediated anti-cancer effect. However, since autophagy is strongly involved in the immunogenicity of cell death by promoting ATP release, its inhibition may reduce the immune response against tumors, negatively influencing the overall outcome of chemotherapy. In this study, we evaluated the

Indexed as

athymic nude miceautophagyBalb/c micecancerchloroquinecurcuminHer2/neu

Identifiers

PMID29147611
PMCPMC5674961
OpenAlexW2740002839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.